Chemed Corporation (CHE) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript
CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursda
Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed's exec
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript

Chemed Reports Fourth-Quarter 2025 Results

04:15pm, Wednesday, 25'th Feb 2026
CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto
Barington Companies Management initiated a 13,000-share position in Chemed during the fourth quarter. The estimated trade value was $5.56 million.
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Ch
Keybank National Association OH cut its position in Chemed Corporation (NYSE: CHE) by 93.6% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 614 shares of
Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on Wednesday, after the worst day for stocks since October. Stocks w
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, Februa
Harbor Capital Advisors Inc. decreased its stake in shares of Chemed Corporation (NYSE: CHE) by 65.3% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund
Shares of Chemed Corporation (NYSE: CHE - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, MarketBeat Ratings rep
CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE